Targeting Iron Acquisition Blocks Infection with the Fungal Pathogens Aspergillus fumigatus and Fusarium oxysporum

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Leal, Sixto M ^a   Roy, Sanhita ^a   Vareechon, Chairut ^a   Carrion, Steven deJesus ^a   Clark, Heather ^a   Lopez Berges, Manuel S ^b   diPietro, Antonio ^b   Schrettl, Marcus ^c   Beckmann, Nicola ^c   Redl, Bernhard ^c   Haas, Hubertus ^c   Pearlman, Eric ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DECTIN 1; DEFERIPRONE; DEFEROXAMINE; HEME; HEPCIDIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; IRON; LIPOCALIN 1; MEVINOLIN; SIDEROPHORE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CORNEA OPACITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FUNGAL STRAIN; FUNGAL VIABILITY; FUNGUS GROWTH; FUSARIOSIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IRON METABOLISM; KERATITIS; MOUSE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; REAL TIME POLYMERASE CHAIN REACTION; STEREOMICROSCOPY;

EID: 84884740645     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003436     Document Type: Article

References (63)

1. Milner JD, Sandler NG, Douek DC, (2010) Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS 5: 179-183.
2. Antachopoulos C, (2010) Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect 16: 1335-1342.
3. Thomas PA, (2003) Fungal infections of the cornea. Eye 17: 852-862.
4. Gower EW, Keay LJ, Oechsler RA, Iovieno A, Alfonso EC, et al. (2010) Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology 117: 2263-2267.
5. World Health Organization (October 2011) Visual Impairment and Blindness- Key Facts. Centre WM, editor.
6. Whitcher JP, Srinivasan M, Upadhyay MP, (2001) Corneal blindness: a global perspective. Bull World Health Organ 79: 214-221.
7. London Fungal Research Trust (2011) How Common are fungal diseases? Available: www.fungalinfectiontrust.org/HowCommonareFungalDiseases2.pdf.
8. Leal SM Jr, Vareechon C, Cowden S, Cobb BA, Latge JP, et al. (2012) Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest 122: 2482-2498.
9. Wood ZA, Schroder E, Robin Harris J, Poole LB, (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40.
10. Winterbourn CC, (2008) Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4: 278-286.
11. Schrettl M, Bignell E, Kragl C, Sabiha Y, Loss O, et al. (2007) Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathog 3: 1195-1207.
12. Haas H, Eisendle M, Turgeon BG, (2008) Siderophores in fungal physiology and virulence. Annu Rev Phytopathol 46: 149-187.
13. Haas H, (2012) Iron- A Key Nexus in the Virulence of Aspergillus fumigatus. Front Microbiol 3: 28.
14. Yasmin S, Alcazar-Fuoli L, Grundlinger M, Puempel T, Cairns T, et al. (2012) Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc Natl Acad Sci U S A 109: E497-504.
15. Hentze MW, Muckenthaler MU, Galy B, Camaschella C, (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24-38.
16. Flanagan JL, Willcox MD, (2009) Role of lactoferrin in the tear film. Biochimie 91: 35-43.
17. Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B, (2004) Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother 48: 3367-3372.
18. Skaar EP, (2010) The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6: e1000949.
19. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A, (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
20. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, et al. (2011) Hepcidin regulation by innate immune and infectious stimuli. Blood 118: 4129-4139.
21. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, et al. (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107: 3727-3732.
22. Ganz T, Nemeth E, (2011) Hepcidin and disorders of iron metabolism. Annu Rev Med 62: 347-360.
23. Leal SM Jr, Cowden S, Hsia YC, Ghannoum MA, Momany M, et al. (2010) Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog 6: e1000976.
24. Karthikeyan RS, Leal SM Jr, Prajna NV, Dharmalingam K, Geiser DM, et al. (2011) Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium. J Infect Dis 204: 942-950.
25. Hider RC, Kong X, (2010) Chemistry and biology of siderophores. Nat Prod Rep 27: 637-657.
26. Correnti C, Strong RK, (2012) Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool. J Biol Chem 287: 13524-13531.
27. Dartt DA, (2011) Tear lipocalin: structure and function. Ocul Surf 9: 126-138.
28. Petrik M, Haas H, Schrettl M, Helbok A, Blatzer M, et al. (2012) In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging. Nucl Med Biol 39: 361-369.
29. Schrettl M, Bignell E, Kragl C, Joechl C, Rogers T, et al. (2004) Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med 200: 1213-1219.
30. Schrettl M, Beckmann N, Varga J, Heinekamp T, Jacobsen ID, et al. (2010) HapX-mediated adaption to iron starvation is crucial for virulence of Aspergillus fumigatus. PLoS Pathog 6: e1001124.
31. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, et al. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
32. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, et al. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5: 476-486.
33. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, et al. (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84: 413-428.
34. Zamocky M, Koller F, (1999) Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis. Prog Biophys Mol Biol 72: 19-66.
35. Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, et al. (2005) Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 1: e30.
36. Gersuk GM, Underhill DM, Zhu L, Marr KA, (2006) Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 176: 3717-3724.
37. Manuel Berges JC, Turra David, Schafferer Lukas, Matthijs Sandra, Jochl Christoph, Cornelis Pierre, Guarro Josep, Haas Hubertus, Di Pietro Antonio, (2012) HapX-Mediated Iron Homeostasis Is Essential for Rhizosphere Competence and Virulence of the Soilborne Pathogen Fusarium oxysporum. Plant Cell 24: 3805-3822.
38. Oide S, Moeder W, Krasnoff S, Gibson D, Haas H, et al. (2006) NPS6, encoding a nonribosomal peptide synthetase involved in siderophore-mediated iron metabolism, is a conserved virulence determinant of plant pathogenic ascomycetes. Plant Cell 18: 2836-2853.
39. Liu H, Gravelat FN, Chiang LY, Chen D, Vanier G, et al. (2010) Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis. Mol Microbiol 78: 1038-1054.
40. Smith MEB, Lee NJ, Haney E, Carson S (2009) Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5. In: University OHS, editor. Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5. Portland (OR).
41. Macreadie IG, Johnson G, Schlosser T, Macreadie PI, (2006) Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett 262: 9-13.
42. Qiao J, Kontoyiannis DP, Wan Z, Li R, Liu W, (2007) Antifungal activity of statins against Aspergillus species. Med Mycol 45: 589-593.
43. Nyilasi I, Kocsube S, Krizsan K, Galgoczy L, Pesti M, et al. (2010) In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol Lett 307: 175-184.
44. Wojnar P, Lechner M, Redl B, (2003) Antisense down-regulation of lipocalin-interacting membrane receptor expression inhibits cellular internalization of lipocalin-1 in human NT2 cells. J Biol Chem 278: 16209-16215.
45. Wojnar P, Lechner M, Merschak P, Redl B, (2001) Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display. J Biol Chem 276: 20206-20212.
46. Fullard RJ, Kissner DM, (1991) Purification of the isoforms of tear specific prealbumin. Curr Eye Res 10: 613-628.
47. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI, (2007) Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 178: 6367-6373.
48. Ma Y, Zhou T, Kong X, Hider RC, (2012) Chelating agents for the treatment of systemic iron overload. Curr Med Chem 19: 2816-2827.
49. Robins-Browne RM, Prpic JK, (1985) Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun 47: 774-779.
50. Boelaert JR, van Roost GF, Vergauwe PL, Verbanck JJ, de Vroey C, et al. (1988) The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clin Nephrol 29: 261-266.
51. Windus DW, Stokes TJ, Julian BA, Fenves AZ, (1987) Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med 107: 678-680.
52. Christopher GW, (1985) Escherichia coli bacteremia, meningitis, and hemochromatosis. Arch Intern Med 145: 1908.
53. Bullen JJ, Spalding PB, Ward CG, Gutteridge JM, (1991) Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med 151: 1606-1609.
54. Abbott M, Galloway A, Cunningham JL, (1986) Haemochromatosis presenting with a double Yersinia infection. J Infect 13: 143-145.
55. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, et al. (2007) Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110: 1303-1306.
56. Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, et al. (2004) Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 34: 505-509.
57. Zarember KA, Cruz AR, Huang CY, Gallin JI, (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53: 2654-2656.
58. Ibrahim AS, Gebremariam T, French SW, Edwards JE Jr, Spellberg B, (2010) The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J Antimicrob Chemother 65: 289-292.
59. Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, et al. (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117: 2649-2657.
60. Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B, (2006) Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 58: 1070-1073.
61. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, et al. (2012) The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67: 715-722.
62. Kontoghiorghes GJ, (2007) Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities. Expert Opin Drug Saf 6: 235-239.
63. Gao J, Chen J, De Domenico I, Koeller DM, Harding CO, et al. (2010) Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 115: 3374-3381.